Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms

MLA

Elena V Yakubova, et al. “Biochemical Profiling of Anti-HIV Prodrug Elsulfavirine (Elpida®) and Its Active Form VM1500A against a Panel of Twelve Human Carbonic Anhydrase Isoforms.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 36, Jan. 2021, pp. 1056–60. EBSCOhost, https://doi.org/10.1080/14756366.2021.1927007.

APA

Elena V Yakubova, Claudiu T. Supuran, Nikolay Savchuk, Alessio Nocentini, Stanislav Kalinin, & Mikhail Krasavin. (2021). Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry, 36, 1056–1060. https://doi.org/10.1080/14756366.2021.1927007

Chicago

Elena V Yakubova, Claudiu T. Supuran, Nikolay Savchuk, Alessio Nocentini, Stanislav Kalinin, and Mikhail Krasavin. 2021. “Biochemical Profiling of Anti-HIV Prodrug Elsulfavirine (Elpida®) and Its Active Form VM1500A against a Panel of Twelve Human Carbonic Anhydrase Isoforms.” Journal of Enzyme Inhibition and Medicinal Chemistry 36 (January): 1056–60. doi:10.1080/14756366.2021.1927007.